Leber’s hereditary optic neuropathy: clinical and genetic analysis of Bulgarian patients

References

• Wallace D, Singh G, Lott M, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science. 1988;242(4884):1–9. doi: 10.1126/science.3201231.
   Web of Science ®Google Scholar
• Fraser J, Biousse V, Newman N. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55(4):299–334. doi: 10.1016/j.survophthal.2009.10.002.
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Turnbull D, Chinnery P. Leber hereditary optic neuropathy. J Med Genet. 2002;39(3):162–169. doi: 10.1136/jmg.39.3.162.
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Griffiths G, Brown D, et al. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72(2):333–339. doi: 10.1086/346066.
   PubMed Web of Science ®Google Scholar
• Bhate M, Kulkarni S, Nalawade R, et al. Clinical and genetic profile of Leber’s hereditary optic neuropathy in a cohort of patients from a tertiary eye care center. J Pediatr Ophthalmol Strabismus. 2022;59(5):344–349. doi: 10.3928/01913913-20220124-02.
   PubMed Web of Science ®Google Scholar
• Howell N. Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve. Vision Res. 1998;38(10):1495–1504. doi: 10.1016/s0042-6989(97)00444-6.
   PubMed Web of Science ®Google Scholar
• Riordan-Eva P, Sanders M, Govan G, et al. The clinical features of Leber’s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain. 1995;118(Pt 2):319–337. doi: 10.1093/brain/118.2.319.
   PubMed Web of Science ®Google Scholar
• Kerrison J, Newman N. Clinical spectrum of Leber’s hereditary optic neuropathy. Clin Neuroscience. 1997;4(5):295–301.
   PubMedGoogle Scholar
• Carelli V, d‘Adamo P, Valentino ML, et al. Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion. Brain. 2016;139(Pt 3):e17. doi: 10.1093/brain/awv339.
   PubMedGoogle Scholar
• Pott J, Wong K. Leber’s hereditary optic neuropathy and vitamin B12 deficiency. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1357–1359. doi: 10.1007/s00417-006-0269-7.
   PubMed Web of Science ®Google Scholar
• Sadun A, Carelli V, Salomao S, et al. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2003;136(2):231–238. doi: 10.1016/s0002-9394(03)00099-0.
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Griffiths P, Chinnery P. Mitochondrial optic neuropathies—disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2):81–114. doi: 10.1016/j.preteyeres.2010.11.002.
   PubMed Web of Science ®Google Scholar
• Giordano C, Montopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy. Brain. 2011;134, 1(Pt 1):220–234. doi: 10.1093/brain/awq276.
   Google Scholar
• Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001;4(6):499–502. doi: 10.1097/00075197-200111000-00006.
   PubMed Web of Science ®Google Scholar
• Power M, Schulkin J. Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr. 2008;99(5):931–940. doi: 10.1017/S0007114507853347.
   PubMed Web of Science ®Google Scholar
• Puomila A, Hämäläinen P, Kivioja S, et al. Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet. 2007;15(10):1079–1089. doi: 10.1038/sj.ejhg.5201828.
   PubMed Web of Science ®Google Scholar
• Mackey D, Oostra R, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet. 1996;59(2):481–485.
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Votruba M, Burte F, et al. A neurodegenerative perspective on mitochondrial optic neuropathies. Acta Neuropathol. 2016;132(6):789–806. doi: 10.1007/s00401-016-1625-2.
   PubMed Web of Science ®Google Scholar
• Newman N, Carelli V, Taiel M, et al. Visual outcomes in Leber hereditary optic neuropathy patients with the m. 11778G > A (MTND4) mitochondrial DNA mutation. J Neuroophthalmol. 2020;40(4):547–557. doi: 10.1097/WNO.0000000000001045.
   PubMed Web of Science ®Google Scholar
• Buchan J, Ong C, Dabbs T. Acute leber hereditary optic neuropathy in a 73-year-old man. Eye (Lond). 2007;21(6):859–860. doi: 10.1038/sj.eye.6702729.
   PubMed Web of Science ®Google Scholar
• Dimitriadis K, Leonhardt M, Yu-Wai-Man P, et al. Leber’s hereditary optic neuropathy with late disease onset: clinical and molecular characteristics of 20 patients. Orphanet J Rare Dis. 2014;9(1):158. doi: 10.1186/s13023-014-0158-9.
   PubMedGoogle Scholar
• Kirkman M, Korsten A, Leonhardt M, et al. Quality of life in patients with leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50(7):3112–3115. doi: 10.1167/iovs.08-3166.
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Votruba M, Moore A, et al. Treatment strategies for inherited optic neuropathies: past, present and future. Eye (Lond). 2014;28(5):521–537. doi: 10.1038/eye.2014.37.
   PubMed Web of Science ®Google Scholar
• Cherninkova S, Zaharova B, Sareva R, et al. Clinical symptoms and genetic studies in patients with Leber’s hereditary optic neuropathy. Bulg Neurol. 2016;17(3):226– 233.
   Google Scholar
• Cherninkova S, Zaharova B, Saraeva R, et al. Leber’s hereditary optic neuropathy in bulgarian patients. C R Acad Bulg Sci. 2020;73(1):125–132.
   Google Scholar
• Cherninkova S, Atemin S, Todorov T, et al. A case of Leber’s hereditary optic neuropathy with a new genetic variant m.15988A > G in the mitochondrial genome. Bulg Neurol. 2018;19(2):62–67.
   Google Scholar
• Ramos A, Santos C, Alvarez L, et al. Human mitochondrial DNA complete amplification and sequencing: a new validated primer set that prevents nuclear DNA sequences of mitochondrial origin co-amplification. Electrophoresis. 2009;30(9):1587–1593. PMID: 19350543. doi: 10.1002/elps.200800601.
   PubMed Web of Science ®Google Scholar
• Volodko N, L’vova M, Starikovskaya E, et al. Spectrum of pathogenic mtDNA mutations in Leber’s hereditary optic neuropathy families from Siberia. Russian J Genet. 2006;42(1):89–97.
   Web of Science ®Google Scholar
• Yang J, Zhu Y, Tong V, et al. Confirmation of the mitochondrial ND1 gene mutation G3635A as a primary LHON mutation. Biochem Biophys Res Commun. 2009;386(1):50–54. doi: 10.1016/j.bbrc.2009.05.127.
   PubMed Web of Science ®Google Scholar
• Bi R, Zhang A, Jia X, et al. Complete mitochondrial DNA genome sequence variation of Chinese families with mutation m.3635G > a and leber hereditary optic neuropathy. Mol Vis. 2012;18:3087–3094.
   PubMed Web of Science ®Google Scholar
• Carroll WM, Mastaglia FL. Leber’s optic neuropathy: a clinical and visual evoked potentials study of affected and asymptomatic members of a six generation family. Brain. 1979;102(3):559–580. doi: 10.1093/brain/102.3.559.
   PubMedGoogle Scholar
• Nikoskelainen E, Hoyt W, Nummelin K. Fundus findings in Leber’s hereditary optic neuroretinopathy. Ophthalmic Paediatr Genet. 1985;5(1-2):125–130. doi: 10.3109/13816818509007866.
   PubMed Web of Science ®Google Scholar
• Nikoskelainen E, Hoyt W, Nummelin K. Ophthalmoscopic findings in Leber’s hereditary optic neuropathy. I. Fundus findings in asymptomatic family members. Arch Ophthalmol. 1982;100(10):1597–1602. doi: 10.1001/­archopht.1982.01030040575003.
   PubMedGoogle Scholar
• Nikoskelainen E, Hoyt W, Nummelin K. Ophthalmoscopic findings in Leber’s hereditary optic neuropathy. II. The fundus findings in the affected family members. Arch Ophthalmol. 1983;101(7):1059–1068. doi: 10.1001/­archopht.1983.01040020061011.
   PubMedGoogle Scholar
• Harding A, Sweeney M, Govan G, et al. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet. 1995;57(1):77–86.
   PubMed Web of Science ®Google Scholar
• McFarland R, Chinnery P, Blakely E, et al. Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology. 2007;69(9):911–916. doi: 10.1212/01.wnl.0000267843.10977.4a.
   PubMed Web of Science ®Google Scholar
• Martikainen M, Ng Y, Gorman G, et al. Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease. JAMA Neurol. 2016;73(6):668–674. doi: 10.1001/jamaneurol.2016.0355.
   PubMed Web of Science ®Google Scholar
• Shu L, Zhang Y, Huang X, et al. Complete mitochondrial DNA sequence analysis in two Southern Chinese pedigrees with Leber hereditary optic neuropathy revealed secondary mutations along with the primary mutation. Int J Ophthalmol. 2015;5(1):28–31.
   Google Scholar
• Klopstock T, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy. Brain. 2011;134(Pt 9):2677–2686. doi: 10.1093/brain/awr170.
   PubMed Web of Science ®Google Scholar
• Klopstock T, Metz G, Yu-Wai-Man P, et al. Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy. Brain. 2013;136(Pt 2):e230.doi: 10.1093/brain/aws279.
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson K. Idebenone: a review in Leber’s hereditary optic neuropathy. Drugs. 2016;76(7):805–813. doi: 10.1007/s40265-016-0574-3.
   PubMed Web of Science ®Google Scholar
• Carelli V, Carbonelli M, de Coo I, et al. International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy. J Neuroophthalmol. 2017;37(4):371–381. doi: 10.1097/WNO.0000000000000570.
   PubMed Web of Science ®Google Scholar
• Catarino C, von Livonius B, Priglinger C, et al. Real-world clinical experience with idebenone in the treatment of Leber hereditary optic neuropathy. J Neuroophthalmol. 2020;40(4):558–565. doi: 10.1097/WNO.0000000000001023.
   PubMed Web of Science ®Google Scholar
• van Everdingen JAM, Pott JWR, Bauer NJC, et al. Clinical outcomes of treatment with idebenone in leber’s hereditary optic neuropathy in The Netherlands: a national cohort study. Acta Ophthalmol. 2022;100(6):700–706. doi: 10.1111/aos.15153.
   PubMed Web of Science ®Google Scholar
• Newman N, Yu-Way-Man P, Carelli V, et al. Efficacy and safety of intraviteral gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset. Ophthalmology. 2021;128(5):649–660. doi: 10.1016/j.ophtha.2020.12.012.
   PubMed Web of Science ®Google Scholar
• Sahel J, Newman N, Yu-Way-Man P, et al. Gene therapies for the treatment of Leber hereditary optic neuropathy. Int Ophthalmol Clin. 2021;61(4):195–208. doi: 10.1097/IIO.0000000000000364.
   PubMedGoogle Scholar
• Carelli V, Newman NJ, Yu-Wai-Man P, the LHON Study Group., et al. Indirect comparison of lenadogene nolparvovec gene therapy versus natural history in patients with Leber hereditary optic neuropathy carrying the m.11778G > a MT-ND4 mutation. Ophthalmol Ther. 2023;12(1):401–429. doi: 10.1007/s40123-022-00611-x.
   PubMed Web of Science ®Google Scholar
• Carper MG, Henderson AD. Updated review of Leber hereditary optic neuropathy. Curr Treat Options Neurol. 2022;24(9):441–452. doi: 10.1007/s11940-022-00729-0.
   Web of Science ®Google Scholar
• Yu-Wai-Man P, Newman NJ, Carelli V, LHON REALITY Study Group., et al. Natural history of patients with leber hereditary optic neuropathy-results from the REALITY study. Eye (Lond). 2022;36(4):818–826. doi: 10.1038/s41433-021-01535-9.
   PubMed Web of Science ®Google Scholar